133 related articles for article (PubMed ID: 29079210)
1. Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses.
Woldu SL; Aydin AM; Rao AV; Hutchinson RC; Singla N; Clinton TN; Krabbe LM; Passoni NM; Raj GV; Miller DS; Amatruda JF; Sagalowsky AI; Lotan Y; Arriaga Y; Margulis V; Bagrodia A
Urology; 2018 Feb; 112():103-111. PubMed ID: 29079210
[TBL] [Abstract][Full Text] [Related]
2. Recent trends in the incidence of testicular germ cell tumors in the United States.
Ghazarian AA; Trabert B; Devesa SS; McGlynn KA
Andrology; 2015 Jan; 3(1):13-8. PubMed ID: 25331158
[TBL] [Abstract][Full Text] [Related]
3. Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.
Ghazarian AA; Kelly SP; Altekruse SF; Rosenberg PS; McGlynn KA
Cancer; 2017 Jun; 123(12):2320-2328. PubMed ID: 28241106
[TBL] [Abstract][Full Text] [Related]
4. Trends in testicular germ cell tumours by ethnic group in the United States.
Shah MN; Devesa SS; Zhu K; McGlynn KA
Int J Androl; 2007 Aug; 30(4):206-13; discussion 213-4. PubMed ID: 17708751
[TBL] [Abstract][Full Text] [Related]
5. Increasing Incidence of Testicular Germ Cell Tumors among Racial/Ethnic Minorities in the United States.
Ghazarian AA; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1237-1245. PubMed ID: 32385118
[TBL] [Abstract][Full Text] [Related]
6. Incidence of testicular germ cell tumors among US men by census region.
Ghazarian AA; Trabert B; Graubard BI; Schwartz SM; Altekruse SF; McGlynn KA
Cancer; 2015 Dec; 121(23):4181-9. PubMed ID: 26280359
[TBL] [Abstract][Full Text] [Related]
7. Update on epidemiologic considerations and treatment trends in testicular cancer.
Woldu SL; Bagrodia A
Curr Opin Urol; 2018 Sep; 28(5):440-447. PubMed ID: 30004908
[TBL] [Abstract][Full Text] [Related]
8. Testicular cancer in Hispanics: incidence of subtypes over time according to neighborhood sociodemographic factors in California.
DeRouen MC; McKinley M; Shah SA; Borno HT; Aoki R; Lichtensztajn DY; Leppert JT; Brooks JD; Chung BI; Gomez SL; Cheng I
Cancer Causes Control; 2020 Aug; 31(8):713-721. PubMed ID: 32440828
[TBL] [Abstract][Full Text] [Related]
9. Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.
Lerro CC; Robbins AS; Fedewa SA; Ward EM
Urol Oncol; 2014 Jan; 32(1):23.e15-21. PubMed ID: 23395701
[TBL] [Abstract][Full Text] [Related]
10. Neonatal Hormone Concentrations and Risk of Testicular Germ Cell Tumors (TGCT).
Morimoto LM; Zava D; McGlynn KA; Stanczyk FZ; Kang AY; Ma X; Wiemels JL; Metayer C
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):488-495. PubMed ID: 29475970
[No Abstract] [Full Text] [Related]
11. Nontesticular cancers in relatives of testicular germ cell tumor (TGCT) patients from multiple-case TGCT families.
McMaster ML; Heimdal KR; Loud JT; Bracci JS; Rosenberg PS; Greene MH
Cancer Med; 2015 Jul; 4(7):1069-78. PubMed ID: 25882629
[TBL] [Abstract][Full Text] [Related]
12. A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome.
Giambartolomei C; Mueller CM; Greene MH; Korde LA
Cancer Epidemiol; 2009 Jul; 33(1):31-6. PubMed ID: 19679044
[TBL] [Abstract][Full Text] [Related]
13. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.
Schaapveld M; van den Belt-Dusebout AW; Gietema JA; de Wit R; Horenblas S; Witjes JA; Hoekstra HJ; Kiemeney LA; Louwman WJ; Ouwens GM; Aleman BM; van Leeuwen FE
Br J Cancer; 2012 Oct; 107(9):1637-43. PubMed ID: 23059747
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival in patients with germ cell testicular cancer: a population-based competing-risks regression analysis.
Gandaglia G; Becker A; Trinh QD; Abdollah F; Schiffmann J; Roghmann F; Tian Z; Montorsi F; Briganti A; Karakiewicz PI; Sun M
Eur J Surg Oncol; 2014 Jan; 40(1):103-12. PubMed ID: 24099755
[TBL] [Abstract][Full Text] [Related]
15. Younger age-at-diagnosis for familial malignant testicular germ cell tumor.
Mai PL; Chen BE; Tucker K; Friedlander M; Phillips KA; Hogg D; Jewett MA; Bodrogi I; Geczi L; Olah E; Heimdal K; Fosså SD; Nathanson KL; Korde L; Easton DF; Dudakia D; Huddart R; Stratton MR; Bishop DT; Rapley EA; Greene MH
Fam Cancer; 2009; 8(4):451-6. PubMed ID: 19609727
[TBL] [Abstract][Full Text] [Related]
16. Recent malignant testicular tumor trend in Japan, a country with an aging population: a large-scale study of 2012-2015 hospital-based cancer registry data.
Kojo K; Kawai K; Kawahara T; Kimura T; Kandori S; Nagumo Y; Nitta S; Kojima T; Okuyama A; Higashi T; Nishiyama H
Jpn J Clin Oncol; 2020 Sep; 50(10):1201-1208. PubMed ID: 32627833
[TBL] [Abstract][Full Text] [Related]
17. Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich.
Hentrich M; Weber N; Bergsdorf T; Liedl B; Hartenstein R; Gerl A
Acta Oncol; 2005; 44(6):529-36. PubMed ID: 16165911
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Kawai T; Tanaka Y;
Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
[TBL] [Abstract][Full Text] [Related]
19. Bilateral testicular germ cell tumours: a single hospital experience.
Morales-Barrera R; Valverde C; Rodón J; Pérez J; Maldonado X; Suárez C; Trilla E; Carles J
Clin Transl Oncol; 2010 Apr; 12(4):299-302. PubMed ID: 20462840
[TBL] [Abstract][Full Text] [Related]
20. Childhood height and risk of testicular germ cell tumors in adulthood.
McGlynn KA; Petrick JL; Gamborg M; Aarestrup J; Baker JL
Int J Cancer; 2018 Aug; 143(4):767-772. PubMed ID: 29508384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]